Our goal is to observational study is to determine feasibility of partial sleep restriction in individuals with CLBP+I and correlation findings with features of central sensitization. * Identify feasibility of sleep restriction protocol * Identify correlation between less sleep and central sensitization Sleep will be monitored for 2 weeks (baseline sleep monitoring period). Then participants will be asked to restrict their sleep to 80% of their normal sleep duration for 5 nights (sleep restriction period). Then sleep will be monitored again for 2 weeks (sleep recovery period).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Sleep Measures
Timeframe: Through study completion, up to 5 weeks
Sleep Measures
Timeframe: Through study completion, up to 5 weeks
Sleep Measures
Timeframe: Through study completion, up to 5 weeks
Pain Measures
Timeframe: Through study completion, up to 5 weeks
Pain Measures
Timeframe: Through study completion, up to 5 weeks